Regenesome Inc.
PrivateLast Round
Pre Seed
Aug 1, 2025
Total Funding Raised
$880,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regenesome Inc. is a biotechnology company that develops anti-aging technology intended for supplements, foods and cosmetics that utilize exosomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Space Technology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenesome Inc. Comparables
Compare Regenesome Inc. with similar companies based on industry and business-model similarity.
Regenesome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 1, 2025 | ||||
| Debt | May 1, 2025 | ||||
| Pre Seed | Oct 21, 2024 |
Regenesome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leave a Nest Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 87% MoM.
- Dec 9, 2025
Monthly visitors increased 1318% MoM, from 68 to 964.
Regenesome Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenesome Inc.'s valuation, stock price, and market status.